Home - Products - Others - Other Targets - 2,3-Dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one

2,3-Dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one

CAS No. 28564-83-2

2,3-Dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one( ——— )

Catalog No. M39014 CAS No. 28564-83-2

2,3-Dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2,3-Dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one
  • Note
    Research use only, not for human use.
  • Brief Description
    2,3-Dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one
  • Description
    2,3-Dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    28564-83-2
  • Formula Weight
    144.13
  • Molecular Formula
    C6H8O4
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 4-(benzyloxy)benzene...

    4-(benzyloxy)benzene-1-sulfonamide is inhibitor of human recombinant CA-7.

  • HIF-1 alpha (556-574...

    This is a hypoxia-inducible factor-1 (HIF-1 a) 19-mer fragment. HIF-1 functions as master regulator of response to oxygen homeostasis. Hypoxia-induced gene expression is initiated when HIF-1 subunit is stabilized in response to a lack of oxygen. This part of HIF-1 binds to the von Hippel-Lindau factor (VHL) an E3 ubiquitin ligase, and the proline 564 is absolutely critical to the binding process.

  • PI-55

    PI-55 (6-(2-hydroxy-3-methylbenzylamino)purine) is a cytokinin receptor inhibitor that exhibits structural similarity to 6-benzylaminopurine (BAP).